Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 896 of 1,261
  1. US 8324207

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  2. US 8324220

    Pyrimidines useful as modulators of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  3. US 8324210

    Pterin analogs

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  4. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  5. US 8324192

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  6. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  7. US 8324200

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  8. US 8324165

    Compositions for treating arthritis comprising HG1023575 polypeptide

    Five Prime Therapeutics, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  9. US 8323686

    Nanostructures suitable for sequestering cholesterol and other molecules

    Northwestern University · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  10. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  11. US 8323962

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  12. US 8323679

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  13. US 8323706

    Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  14. US 8324242

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  15. US 8324395

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  16. US 8324201

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  17. US 8324171

    Ophthalmic compositions containing diglycine

    BURKE SUSAN E [US] · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  18. US 8324178

    Method of treatment using alpha-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  19. US 8324203

    Azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  20. US 2012301425

    NOVEL ANTITUMORAL USE OF CABAZITAXEL

    GUPTA SUNIL [US] · Granted Nov 29, 2012 · Expires Nov 24, 2032

    granted
  21. WO 2012159962

    COMPOSITION PHARMACEUTIQUE CONTENANT DU KÉTOPROFÈNE

    AVENTIS PHARMA SA [FR] · Granted Nov 29, 2012 · Expires Nov 24, 2032

    granted
  22. DE 102011076653

    Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure

    ACINO AG [DE] · Granted Nov 29, 2012 · Expires Nov 24, 2032

    granted
  23. US 8318483

    Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

    Advanced Technologies and Regenerative Medicine, LLC · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  24. US 8318727

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.